Clinical efficacy and adverse events of baricitinib treatment for coronavirus disease‐2019 (COVID‐19): A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Clinical efficacy and adverse events of baricitinib treatment for coronavirus disease‐2019 (COVID‐19): A systematic review and meta‐analysis

Published:2021-12-13 Issue: Volume: Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Lin Zhiwei¹,Niu Jianyi¹,Xu Yifan¹,Qin Lijie¹,Ding Jiabin¹,Zhou Luqian¹

Affiliation:

1. State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health First Affiliated Hospital of Guangzhou Medical University Guangzhou China

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27482

Reference46 articles.

1. Weekly epidemiological update on COVID‐19 − 2021.https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19

2. The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID‐19;Ye Q;J Infect,2020

3. The interplay between inflammatory pathways and COVID‐19: A critical review on pathogenesis and therapeutic options;Choudhary S;Microb Pathog,2021

4. Nano‐curcumin therapy, a promising method in modulating inflammatory cytokines in COVID‐19 patients;Valizadeh H;Int Immunopharmacol,2020

5. The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID‐19;Goker Bagca B;Cytokine Growth Factor Rev,2020

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIGH THROUGHPUT QUANTITATION OF HUMAN NEUTROPHIL RECRUITMENT AND FUNCTIONAL RESPONSES IN AN AIR-BLOOD BARRIER ARRAY;2024-05-14

2. Secondary infections and long-term outcomes among hospitalized elderly and non-elderly patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and treated with baricitinib: a comparative study from the national centre of Hungary;GeroScience;2024-02-17

3. The interference between SARS-COV-2 and Alzheimer’s disease: Potential immunological and neurobiological crosstalk from a kinase perspective reveals a delayed pandemic;Ageing Research Reviews;2024-02

4. Medicinal chemistry perspective of JAK inhibitors: synthesis, biological profile, selectivity, and structure activity relationship;Molecular Diversity;2024-01-18

5. JAK Inhibitors in Cytokine Storm Syndromes;Advances in Experimental Medicine and Biology;2024